13F filer · CIK 1715579
Medicxi Ventures Management (Jersey) Ltd
ST. HELIER, Y9 · filing since Q4 2019 · last filing Nov 2, 2026
Reported value
$126.7M
$-50.8M vs prior
Positions
3
New / sold out
0 / 0
Added / reduced
0 / 1
Turnover
0.0%
buys $0 · sells $639.6K
Top-10 weight
100.0%
Biggest buys vs Q2 2026
No new or increased positions this quarter.
Biggest sells vs Q2 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Reduced | NEWAMSTERDAM PHARMA COMPANY | -26,300 | -1.2% | $-639.6K |
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q3 2026
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | PHATHOM PHARMACEUTICALS INCCOM | 7,464,572 | $54.5M | 43.02% |
| 2 | NEWAMSTERDAM PHARMA COMPANYORDINARY SHARES | 2,182,339 | $53.1M | 41.90% |
| 3 | AURA BIOSCIENCES INCCOM | 3,039,892 | $19.1M | 15.07% |